TARBP2 and acute myeloid leukemia: These findings indicate that while most miRNA biogenesis genes exhibit stable expression across clinical subgroups, DGCR8 in MDS and TARBP2 in AML display disease-related transcriptional alterations that may be linked to disease severity or differentiation status.